Investigating a novel suppressor protein interacting with an adaptor protein in ubiquitination & cancer progression.

Analyzing single-cell RNA-seq & proteomics datasets from breast cancer samples to study tumor microenvironments.

Discovering biomarkers for breast cancer using cell-free DNA for early non-invasive diagnostics.

Computer-aided drug design (CADD) & novel drug development against cancer targets.

Molecular docking, dynamics simulations, and gene expression analysis.

Molecular mechanisms of protein glycosylation in breast cancer progression.

Role of RNA Binding Proteins (RBPs) on c-Myc regulation in breast cancer.

Visiting Ph.D. scholar studying RBP interactions with breast cancer oncogenes.

Investigated glycosylation-related genes in breast cancer progression.

Single-cell and bulk RNA-seq end-to-end processing pipeline development.

Functional analysis of novel metabolic genes in cancer.

Bulk RNA-seq pathway analysis in Triple Negative Breast Cancer (TNBC).

Gene characterization in key cancer signaling pathways.

Computational analysis & modeling of Single Cell Sequencing data.

Identification of novel cancer signaling genes via computational methods.

Breast cancer tissue expression profiling of oncogenes using Immunohistochemistry (IHC).

Binding interaction studies between novel drug candidates and targeted oncogenes.